Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma

Narayan Shivapurkar, Arvind K. Virmani, Ignacio I. Wistuba, Sara Milchgrub, Bruce Mackay, John D. Minna, Adi F. Gazdar

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Recent allelotyping studies suggest that allelic losses at one or both arms of chromosome 4 are frequent in several tumor types. Cytogenetic studies of malignant mesothelioma (MM) and comparative genomic hybridization analyses of small cell lung carcinoma (SCLC) suggest that chromosome 4 deletions may also play a role in these tumor types, although these results have not been confirmed by allelotyping. In an effort to more precisely identify and map the locations of putative tumor suppressor gene(s) on chromosome 4 involved in the pathogenesis of these tumors, we performed loss of heterozygosity studies using 16 polymorphic microsatellite markers. After precise microdissection of archival surgical cases, we studied DNA obtained from 20 MMs, 21 SCLCs, and 20 non-SCLCs (NSCLCs). In addition, DNA from 14 SCLC and 17 NSCLC cell lines and corresponding B lymphoblastoid lines were studied. In MM and SCLC, we observed frequent losses at three nonoverlapping regions: (a) 4q33-34 (region R1; >80%); (b) 4q25-26 (region R2; >60%); and (c) 4p15.1- 15.3 (region R3; >50%). Losses at these sites occurred at lower frequencies in NSCLC (>20-30%). Data from tumors and cell lines were similar. In MM and SCLC, the most frequently observed pattern was loss at all three regions. However, in NSCLC, the most frequent pattern was loss at R3 alone. Our study has delineated three nonoverlapping regions of frequent deletions on chromosome 4 in MM and SCLC, suggesting that there may be three putative suppressor genes on chromosome 4, the inactivation of which may be important in the pathogenesis of these tumor types.

Original languageEnglish (US)
Pages (from-to)17-23
Number of pages7
JournalClinical Cancer Research
Volume5
Issue number1
StatePublished - 1999

Fingerprint

Chromosomes, Human, Pair 4
Small Cell Lung Carcinoma
Loss of Heterozygosity
Neoplasms
Suppressor Genes
Chromosome Deletion
Microdissection
Comparative Genomic Hybridization
DNA
Tumor Cell Line
Tumor Suppressor Genes
Non-Small Cell Lung Carcinoma
Cytogenetics
Microsatellite Repeats
Malignant Mesothelioma
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. / Shivapurkar, Narayan; Virmani, Arvind K.; Wistuba, Ignacio I.; Milchgrub, Sara; Mackay, Bruce; Minna, John D.; Gazdar, Adi F.

In: Clinical Cancer Research, Vol. 5, No. 1, 1999, p. 17-23.

Research output: Contribution to journalArticle

Shivapurkar, Narayan ; Virmani, Arvind K. ; Wistuba, Ignacio I. ; Milchgrub, Sara ; Mackay, Bruce ; Minna, John D. ; Gazdar, Adi F. / Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. In: Clinical Cancer Research. 1999 ; Vol. 5, No. 1. pp. 17-23.
@article{3a9d8445dca14750b2af32a3f3b45b7f,
title = "Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma",
abstract = "Recent allelotyping studies suggest that allelic losses at one or both arms of chromosome 4 are frequent in several tumor types. Cytogenetic studies of malignant mesothelioma (MM) and comparative genomic hybridization analyses of small cell lung carcinoma (SCLC) suggest that chromosome 4 deletions may also play a role in these tumor types, although these results have not been confirmed by allelotyping. In an effort to more precisely identify and map the locations of putative tumor suppressor gene(s) on chromosome 4 involved in the pathogenesis of these tumors, we performed loss of heterozygosity studies using 16 polymorphic microsatellite markers. After precise microdissection of archival surgical cases, we studied DNA obtained from 20 MMs, 21 SCLCs, and 20 non-SCLCs (NSCLCs). In addition, DNA from 14 SCLC and 17 NSCLC cell lines and corresponding B lymphoblastoid lines were studied. In MM and SCLC, we observed frequent losses at three nonoverlapping regions: (a) 4q33-34 (region R1; >80{\%}); (b) 4q25-26 (region R2; >60{\%}); and (c) 4p15.1- 15.3 (region R3; >50{\%}). Losses at these sites occurred at lower frequencies in NSCLC (>20-30{\%}). Data from tumors and cell lines were similar. In MM and SCLC, the most frequently observed pattern was loss at all three regions. However, in NSCLC, the most frequent pattern was loss at R3 alone. Our study has delineated three nonoverlapping regions of frequent deletions on chromosome 4 in MM and SCLC, suggesting that there may be three putative suppressor genes on chromosome 4, the inactivation of which may be important in the pathogenesis of these tumor types.",
author = "Narayan Shivapurkar and Virmani, {Arvind K.} and Wistuba, {Ignacio I.} and Sara Milchgrub and Bruce Mackay and Minna, {John D.} and Gazdar, {Adi F.}",
year = "1999",
language = "English (US)",
volume = "5",
pages = "17--23",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma

AU - Shivapurkar, Narayan

AU - Virmani, Arvind K.

AU - Wistuba, Ignacio I.

AU - Milchgrub, Sara

AU - Mackay, Bruce

AU - Minna, John D.

AU - Gazdar, Adi F.

PY - 1999

Y1 - 1999

N2 - Recent allelotyping studies suggest that allelic losses at one or both arms of chromosome 4 are frequent in several tumor types. Cytogenetic studies of malignant mesothelioma (MM) and comparative genomic hybridization analyses of small cell lung carcinoma (SCLC) suggest that chromosome 4 deletions may also play a role in these tumor types, although these results have not been confirmed by allelotyping. In an effort to more precisely identify and map the locations of putative tumor suppressor gene(s) on chromosome 4 involved in the pathogenesis of these tumors, we performed loss of heterozygosity studies using 16 polymorphic microsatellite markers. After precise microdissection of archival surgical cases, we studied DNA obtained from 20 MMs, 21 SCLCs, and 20 non-SCLCs (NSCLCs). In addition, DNA from 14 SCLC and 17 NSCLC cell lines and corresponding B lymphoblastoid lines were studied. In MM and SCLC, we observed frequent losses at three nonoverlapping regions: (a) 4q33-34 (region R1; >80%); (b) 4q25-26 (region R2; >60%); and (c) 4p15.1- 15.3 (region R3; >50%). Losses at these sites occurred at lower frequencies in NSCLC (>20-30%). Data from tumors and cell lines were similar. In MM and SCLC, the most frequently observed pattern was loss at all three regions. However, in NSCLC, the most frequent pattern was loss at R3 alone. Our study has delineated three nonoverlapping regions of frequent deletions on chromosome 4 in MM and SCLC, suggesting that there may be three putative suppressor genes on chromosome 4, the inactivation of which may be important in the pathogenesis of these tumor types.

AB - Recent allelotyping studies suggest that allelic losses at one or both arms of chromosome 4 are frequent in several tumor types. Cytogenetic studies of malignant mesothelioma (MM) and comparative genomic hybridization analyses of small cell lung carcinoma (SCLC) suggest that chromosome 4 deletions may also play a role in these tumor types, although these results have not been confirmed by allelotyping. In an effort to more precisely identify and map the locations of putative tumor suppressor gene(s) on chromosome 4 involved in the pathogenesis of these tumors, we performed loss of heterozygosity studies using 16 polymorphic microsatellite markers. After precise microdissection of archival surgical cases, we studied DNA obtained from 20 MMs, 21 SCLCs, and 20 non-SCLCs (NSCLCs). In addition, DNA from 14 SCLC and 17 NSCLC cell lines and corresponding B lymphoblastoid lines were studied. In MM and SCLC, we observed frequent losses at three nonoverlapping regions: (a) 4q33-34 (region R1; >80%); (b) 4q25-26 (region R2; >60%); and (c) 4p15.1- 15.3 (region R3; >50%). Losses at these sites occurred at lower frequencies in NSCLC (>20-30%). Data from tumors and cell lines were similar. In MM and SCLC, the most frequently observed pattern was loss at all three regions. However, in NSCLC, the most frequent pattern was loss at R3 alone. Our study has delineated three nonoverlapping regions of frequent deletions on chromosome 4 in MM and SCLC, suggesting that there may be three putative suppressor genes on chromosome 4, the inactivation of which may be important in the pathogenesis of these tumor types.

UR - http://www.scopus.com/inward/record.url?scp=0032900984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032900984&partnerID=8YFLogxK

M3 - Article

C2 - 9918198

AN - SCOPUS:0032900984

VL - 5

SP - 17

EP - 23

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -